The protective effects of chronic intermittent hypobaric hypoxia pretreatment against collagen-induced arthritis in rats

Journal of Inflammation (United Kingdom)

Volumn 12, Issue 1, 2015, Pages

  Shi, Min ^a   Cui, Fang ^a   Liu, Ai Jing ^a   Ma, Hui Jie ^a   Cheng, Ming ^a   Song, Shu Xia ^a   Yuan, Fang ^a   Li, De Pei ^b   Zhang, Yi ^a,c,d  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF TEXAS   (United States)

^c Hebei Key Laboratory of Medical Biotechnology   (China)

^d Hebei Collaborative Innovation Center for Cardio cerebrovascular Disease   (China)

Author keywords

Chronic intermittent hypobaric hypoxia; HIF 1 ; NF B; Rat; Rheumatoid arthritis; T lymphocytes; Th1 Th2

Indexed keywords

CD4 ANTIBODY; FLUORESCEIN ISOTHIOCYANATE; GAMMA INTERFERON; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 17; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHRONIC INTERMITTENT HYPOBARIC HYPOXIA; CLINICAL FEATURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; DOWN REGULATION; EDEMA; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOPATHOLOGY; HYPOBARISM; HYPOXIA; IMMUNE RESPONSE; MALE; NONHUMAN; OPTICAL DENSITY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAT; SYNOVIUM; TH1 CELL; TH2 CELL; THICKNESS;

RATTUS;

EID: 84926643950     PISSN: None     EISSN: 14769255     Source Type: Journal    
DOI: 10.1186/s12950-015-0068-1     Document Type: Article

References (35)

1. Deng S, Xi Y, Wang H, Hao J, Niu X, Li W, et al. Regulatory effect of vasoactive intestinal peptide on the balance of Treg and Th17 in collagen-induced arthritis. Cell Immunol. 2010;265(2):105-10.
2. Zhang Y, Yang HT, Zhou ZN. The cardioprotection of intermittent hypoxic adaptation. Acta Physiologica Sinica. 2007;5:601-13.
3. Guan Y, Gao L, Ma HJ, Li Q, Zhang H, Yuan F, et al. Chronic intermittent hypobaric hypoxia decreases beta-adrenoceptor activity in right ventricular papillary muscle. Am J Physiol Heart Circ Physiol. 2010;298(4):1267-72.
4. Zhu XH, Yan HC, Zhang J, Qu HD, Qiu XS, Chen L, et al. Intermittent hypoxia promotes hippocampal neurogenesis and produces antidepressant-like effects in adult rats. J Neurosci. 2010;30(38):12653-63.
5. Serebrovskaya TV, Manukhina EB, Smith ML, Downey HF, Mallet RT. Intermittent hypoxia: cause of or therapy for systemic hypertension? Exp Biol Med (Maywood). 2008;233(6):627-50.
6. Roels B, Bentley DJ, Coste O, Mercier J, Millet GP. Effects of intermittent hypoxic training on cycling performance in well-trained athletes. Eur J Appl Physiol. 2007;101(3):359-68.
7. Serebrovskaya TV, Swanson RJ, Kolesnikova EE. Intermittent hypoxia: mechanisms of action and some applications to bronchial asthma treatment. J Physiol Pharmacol. 2003;54(1):35-41.
8. Shi M, Cui F, Yang CY, Zhang H, Wang YP, Wei L, et al. Effects of chronic intermittent hypobaric hypoxia on immune function in rat. Chinese J Appl Physiol. 2009;25(4):433-8.
9. Shi M, Cui F, Liu AJ, Li J, Ma HJ, Cheng M, et al. The protection of chronic intermittent hypobaric hypoxia against collagen-induced arthritis in rat through increasing apoptosis. Sheng Li Xue Bao (Acta Physiologica Sinica). 2011;63(2):115-23.
10. Courtenay JS, Dallman MJ, Dayan AD, Martin A, Mosedale B. Immunisation against heterologous type II collagen induces arthritis in mice. Nature. 1980;283(5748):666-8.
11. Soslow RA, Dannenberg AJ, Rush D, Woerner BM, Khan KN, Masferrer J, et al. Cox-2 is expressed in human pulmonary, colonic, and mammary tumors. Cancer. 2000;89(12):2637-45.
12. McInnes IB, Schett G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol. 2007;7:429-42.
13. Annunziato F, Cosmi L, Liotta F, Maggi E, Romagnani S. Type 17 T helper cells-origins, features and possible roles in rheumatic disease. Nat Rev Rheumatol. 2009;5(6):325-31.
14. Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH, et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol. 2005;6(11):1133-41.
15. Parsonage G, Filer A, Bik M, Hardie D, Lax S, Howlett K, et al. Prolonged, granulocyte-macrophage colony-stimulating factor-dependent, neutrophil survival following rheumatoid synovial fibroblast activation by IL-17 and TNFalpha. Arthritis Res Ther. 2008;10(2):R47.
16. van den Berg WB, Miossec P. IL-17 as a future therapeutic target for rheumatoid arthritis. Nat Rev Rheumatol. 2009;5(10):549-53.
17. Boissier MC. Cell and cytokine imbalances in rheumatoid synovitis. Joint Bone Spine. 2011;78(3):230-4.
18. Brennan FM, McInnes IB. Evidence that cytokines play a role in rheumatoid arthritis. J Clin Invest. 2008;118(11):3537-45.
19. Zwerina J, Hayer S, Tohidast-Akrad M, Bergmeister H, Redlich K, Feige U, et al. Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction. Arthritis Rheum. 2004;50(1):277-90.
20. Williams RO, Inglis JJ, Simelyte E, Criado G, Sumariwalla PF. Analysing the effect of novel therapies on cytokine expression in experimental arthritis. Int J Exp Pathol. 2005;86(5):267-78.
21. Hussein MR, Fathi NA, El-Din AM, Hassan HI, Abdullah F, Al-Hakeem E, et al. Alterations of the CD4+, CD8+ T Cell Subsets, Interleukins-1β, IL-10, IL-17, Tumor Necrosis Factor-α and Soluble Intercellular Adhesion Molecule-1 in Rheumatoid Arthritis and Osteoarthritis: Preliminary Observations. Pathol Oncol Res. 2008;14(3):321-8.
22. Ohta S, Harigai M, Tanaka M, Kawaguchi Y, Sugiura T, Takagi K, et al. Tumor necrosis factor-alpha (TNF-alpha) converting enzyme contributes to production of TNF-alpha in synovial tissues from patients with rheumatoid arthritis. J Rheumatol. 2001;28(8):1756-63.
23. Nomura T, Abe Y, Yoshioka Y, Nakagawa S, Tsunoda S, Tsutsumi Y. Creation of TNFR1-selective antagonist and its therapeutic effects. Yakugaku Zasshi. 2010;130(1):63-8.
24. Elenkov IJ, Chrousos GP, Wilder RL. Neuroendocrine regulation of IL-12 and TNF-alpha/IL-10 balance. Clinical implications. Ann N Y Acad Sci. 2000;917:94-105.
25. Brown KD, Claudio E, Siebenlist U. The roles of the classical and alternative nuclear factor-kappaB pathways: potential implications for autoimmunity and rheumatoid arthritis. Arthritis Res Ther. 2008;10(4):212.
26. Westra J, Molema G, Kallenberg CG. Hypoxia-inducible factor-1 as regulator of angiogenesis in rheumatoid arthritis-therapeutic implications. Curr Med Chem. 2010;17(3):254-63.
27. Benito MJ, Murphy E, Murphy EP, van den Berg WB, FitzGerald O, Bresnihan B. Increased synovial tissue NF-kappa B1 expression at sites adjacent to the cartilage-pannus junction in rheumatoid arthritis. Arthritis Rheum. 2004;50(6):1781-7.
28. Giatromanolaki A, Sivridis E, Maltezos E, Athanassou N, Papazoglou D, Gatter KC, et al. Upregulated hypoxia inducible factor-1alpha and -2alpha pathway in rheumatoid arthritis and osteoarthritis. Arthritis Res Ther. 2003;5(4):193-201.
29. Haddad JJ, Harb HL. Cytokines and the regulation of hypoxia-inducible factor (HIF)-1alpha. Int Immunopharmacol. 2005;5(3):461-83.
30. Gaber T, Dziurla R, Tripmacher R, Burmester GR, Buttgereit F. Hypoxia inducible factor (HIF) in rheumatology: low O2! See what HIF can do! Ann Rheum Dis. 2005;64(7):971-80.
31. Taylor CT. Interdependent roles for hypoxia inducible factor and nuclear factor-kappaB in hypoxic inflammation. J Physiol. 2008;586(17):4055-9.
32. Görlach A, Bonello S. The cross-talk between NF-kappaB and HIF-1: further evidence for a significant liaison. Biochem J. 2008;412(3):17-9.
33. Tissot van Patot MC, Serkova NJ, Haschke M, Kominsky DJ, Roach RC, Christians U, et al. Enhanced leukocyte HIF-1alpha and HIF-1 DNA binding in humans after rapid ascent to 4300 m. Free Radic Biol Med. 2009;46(11):1551-7.
34. Meerson F, Pozharov V, Minyailenko T. Superresistance against hypoxia after preliminary adaptation to repeated stress. J Appl Physiol. 1994;76:1856-61.
35. Meerson FZ, Frolov BA, Volianik MN, Boev VM, Bannikov VK, Smoliagin AI, et al. The effect of adaptation to the periodic action of hypoxia on the indices of the immunity system and on the course of allergic diseases. Patol Fiziol Eksp Ter. 1990;3:16-21.